Skip to main content
Premium Trial:

Request an Annual Quote

Shimadzu, NEC, National Center for Biotechnology Information, Susan Clark, Doug Rau, Agostino Fede

Premium

New Products

Shimadzu and NEC launched this week a proteomics analysis data management software called SOLPHI. The software tests data for protein analysis based on two-dimensional electrophoresis. It is based on NEC's proprietary protein analysis support system BioPrism.

The SOLPHI software for up to 10 users sells for $26,000. NEC is in charge of support, while Shimadzu handles sales.


The National Center for Biotechnology Information has released RefSeq 13 at ftp://ftp.ncbi.nih.gov/refseq/release/. The release includes 1,899,454 proteins and sequences from 3,060 different organisms.

 

Movers & Shakers

Susan Clark joined Dynex Technologies as vice president of sales and marketing, Dynex's parent company, Magellan Biosciences, said this week.

Clark previously served as sales manager for Thermo Electron's trace chemical analysis group, part of its scientific instrument division.

Clark holds a BS in biology from the University of Akron in Ohio.


Sigma-Aldrich has named Doug Rau as its vice president of human resources, Sigma-Aldrich said this week.

Rau most recently served as vice president of human resources at Kellwood, an apparel company. He also served as Kellwood's director of training and development for five years.

Rau holds an MBA degree from Saint Louis University and a BA in business administration from the University of Missouri, Columbia.


Agostino Fede has been appointed senior vice president of global central labs of PPD and will take the position next March, the company said last week.

PPD recently changed its name from Medical Research Laboratories International.

Fede most recently served as chief executive officer and founder of Vizyo, a drug development informatics venture in Geneva, and previously served as vice president of operations and sales director for Covance Central Laboratories in Europe.

He has also held management positions with CR Bard and the diagnostics division of Abbott Laboratories.

Fede holds an MS and PhD in molecular biology and biophysics from the Swiss Federal Institute of Technology and also earned an MBA from Ashridge Business School in the UK.